Alan Fuhrman
CIK 1303521 · Chief Financial Officer · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.14M
Companies
8
Total Filings
43
Lifetime Open-Market Net
-$315.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | Chief Financial Officer | 36,164 | $26.99 | $976.1K | $152.0K | 12 | 2026-05-07 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 0 | $46.99 | $0 | $0 | 8 | 2025-07-02 |
| ESPR | Director | 53,404 | $3.15 | $168.2K | $0 | 6 | 2024-05-24 |
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | See Remarks | — | $10.50 | — | $0 | 3 | 2022-05-31 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 0 | — | — | -$467.4K | 7 | 2019-02-15 |
| SYNLOGIC, INC. (MIRN) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2016-03-14 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Chief Financial Officer | 0 | $0.54 | $0 | $0 | 3 | 2014-11-12 |
| ACHIEVE LIFE SCIENCES, INC. (SNUS) Delisted | Senior Vice President & CFO | — | — | — | $0 | 2 | 2008-03-20 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-24 | ESPR | Grant (A) | +23,000 | $0 | EDGAR |
| 2024-05-17 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,095 | $0 | EDGAR |
| 2024-03-19 | TYRA | Grant (A) | +932 | $11.6K | EDGAR |
| 2023-09-19 | TYRA | Grant (A) | +1,463 | $18.3K | EDGAR |
| 2023-08-01 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | ESPR | Grant (A) | +5,150 | $0 | EDGAR |
| 2023-05-25 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,648 | $0 | EDGAR |
| 2023-01-03 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-05-27 | ESPR | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.